Medically Reviewed by: Dr. Dipak Ladda, M.D.
Expertise: Consultant Pathologist
Last Updated: August 5, 2026
Medical Analysis
Comprehensive Clinical Evaluation, Pathophysiology, and Diagnostic Strategies for Anti-Thyroglobulin (ATG) Antibodies
Clinical Introduction and Pathophysiology of Anti-Thyroglobulin Antibodies
Thyroglobulin (Tg) is a large glycoprotein with a molecular weight of 600,000 that is stored within the follicular colloid of the thyroid gland [3]. Thyroglobulin functions as a prohormone in the intrathyroid synthesis of T3, known as Triiodothyronine, and T4, known as Thyroxine [3]. Autoantibodies against thyroglobulin reflect autoimmune thyroid disease and are commonly observed in Hashimoto’s and Graves’ disease [1, 2]. This represents an autoimmune disorder in which the body’s immune system produces antibodies that attack its own healthy cells, which in this specific context interferes with the normal generation and storage of thyroglobulin [3]. Furthermore, anti-thyroglobulin antibodies also exist in ten percent of the normal population and in more than twenty percent of individuals with thyroid cancer [6, 8].
Comprehensive Clinical Indications, Patient History, and Diagnostic Testing Methods
The evaluation of autoimmune thyroid diseases encompasses several critical clinical indicators [12, 13]. Specific indications involve the diagnosis and monitoring of autoimmune thyroid diseases such as Hashimoto’s thyroiditis and Graves’ disease [1, 4]. Additional applications include the evaluation of suspected or proven thyroid cancer presented in the form of a nodule, where thyroglobulin acts as a tumor marker, and the diagnosis of subacute thyroiditis and silent thyroiditis [6, 11]. Testing is also vital during investigations of unexplained hypothyroidism or hyperthyroidism, the assessment of thyroid involvement in non-thyroid-related autoimmune disorders such as Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE), and the comprehensive assessment of infertility [2, 7, 14].
Various laboratory methodologies utilized for estimation include High Performance Liquid Chromatography-Tandem Mass Spectrometry (HPLC-MS/MS), highly sensitive radioimmunoassay (RIA), chemiluminescent immunoassay (ICMA), immunoenzymatic assay (sandwich format), enzyme-linked immunosorbent assay (ELISA), immunometric assay (IMA), indirect immunofluorescence (IIF), passive hemagglutination, and agar gel diffusion precipitation [5, 9, 10].
Comparative Analysis of Analytical Estimation Methods and Clinical Indicators
| Clinical Indication | Diagnostic Application and Relevance |
| Autoimmune Thyroid Diseases | Evaluation of Hashimoto’s thyroiditis and Graves’ disease [1, 4] |
| Treatment Monitoring | Monitoring therapy in autoimmune thyroiditis [1] |
| Thyroid Cancer | Evaluation of suspected or proved thyroid nodules, serving as a tumor marker [6, 11] |
| Thyroiditis Diagnosis | Diagnosis of subacute and silent thyroiditis [15] |
| Unknown Causes | Investigation of unexplained hypothyroidism or hyperthyroidism [7, 14] |
| Autoimmune Disorders | Assessment of thyroid involvement in non-thyroid conditions like RA and SLE [2] |
| Infertility | Clinical assessment of infertility factors [8] |
Patient Preparation, Sample Collection, and Handling Protocols
Prior to sample collection, specific patient guidelines must be meticulously followed to prevent analytical interference [12]. A fasting sample is the preferred choice, and it is advised to fast for twelve hours before taking the blood sample [12]. Patients should also stop dietary supplements containing vitamin B7—commonly found in nail, hair, and skin supplements—biotin, or multivitamins, as these medications heavily interfere with test results [12]. Additionally, oral contraceptives should be discontinued prior to testing because they can produce falsely high values [12].
For sample collection, gather a 3.0 ml blood sample in a plain tube with a red cap, separate the serum as early as possible after collection, and send it promptly to the laboratory [12].
Reference Ranges and Value Interpretations by Age and Component
Thyroglobulin Antibody Reference Range
| Components | Reference Range | Interpretation |
| Thyroglobulin Antibody | 0.0-4.0 IU/mL [12] | Negative [12] |
Note: Results may vary with different methods and from laboratory to laboratory. Readers should refer to the specific kit inserts provided [12, 13].
Reference Range by Age for LC-MS/MS
| Components and Age Group | Reference Range |
| Thyroglobulin by LC-MS/MS (6 months – 3 years) | 7.4 – 48.7 ng/mL [12] |
| Thyroglobulin by LC-MS/MS (4 – 7 years) | 4.1 – 40.5 ng/mL [12] |
| Thyroglobulin by LC-MS/MS (8 – 17 years) | 0.8 – 29.4 ng/mL [12] |
| Thyroglobulin by LC-MS/MS (18 years and older) | 1.3 – 31.8 ng/mL [12] |
Note: Results may vary with different methods and from laboratory to laboratory. Readers should refer to the specific kit inserts provided [12, 13].
Comprehensive Clinical Significance and Disease Correlation Summary
High levels of anti-thyroid antibodies are seen in thyroid disorders like hyperthyroidism, hypothyroidism, Hashimoto’s thyroiditis, autoimmune thyroiditis, Graves’ disease, Type 1 diabetes mellitus, rheumatoid arthritis, thyroid cancer, pernicious anaemia, and scleroderma, whereas slightly raised levels can also be observed across these conditions [2].
| Conditions | Relevance |
| Hashimoto thyroiditis | Diagnosis, disease marker [1, 4] |
| Graves disease | Supports autoimmune etiology [1] |
| Differentiated thyroid carcinoma | Monitors recurrence and interferes with Tg measurements [6, 11] |
| Chronic autoimmune thyroiditis | Confirms ongoing autoimmunity [4] |
| Hypothyroidism risk | Predicts progression [14] |
| Prognosis | Indicates severity and activity [6] |
| Interference | Affects thyroglobulin tumor marker assays [5, 16] |
Analytical Limitations, Interference Factors, and Diagnostic Constraints
Several limitations and interferences must be accounted for during interpretation [12]. Individuals who have been regularly exposed to animals or received immunotherapy or diagnostic procedures utilizing immunoglobulins or immunoglobulin fragments may produce antibodies, such as Human Anti-Mouse Antibodies (HAMA), that severely interfere with immunoassays [12]. Heterophile antibodies, including human anti-goat antibodies, may also be present in patient samples and distort results [12]. Thyroglobulin antibody results must always be interpreted in light of the total clinical presentation of the patient, encompassing symptoms, clinical history, data from additional tests, and other appropriate information [12, 13]. Furthermore, age and gender factors play a role, as older people, especially women, may naturally present with raised antithyroglobulin antibodies [8]. Trusted insights curated by Dr. Dipak Ladda [12].
For Non-Medicos
Understanding Thyroid Autoantibodies and Common Symptoms
Thyroid health relies heavily on balanced immune responses and proper hormone storage [3]. When the body’s immune system experiences a disruption, it can mistakenly generate anti-thyroglobulin (ATG) antibodies that target thyroid tissue [3]. This process can trigger common presenting symptoms such as fatigue, weight gain or loss, cold intolerance, heat intolerance, goiter or neck swelling, hoarseness of voice, dry skin, hair loss, constipation, diarrhea, menstrual irregularities, infertility, depression and mood changes, palpitations, and tremors [7, 8].
Patient Guide to Blood Sample Collection and Results Interpretation
Undergoing the ATG antibody test helps doctors evaluate autoimmune conditions like Hashimoto’s thyroiditis and Graves’ disease [1, 4]. To ensure accuracy, patients should fast for twelve hours, avoid biotin or hair, skin, and nail supplements, and stop oral contraceptives before testing [12]. A clinician will collect 3.0 ml of blood in a red-capped tube, separate the serum, and analyze it [12]. Normal values fall between 0.0 and 4.0 IU/mL (negative), while elevated levels point toward underlying autoimmune activity or specific thyroid disorders [1, 12].
References:
Davies TF, et al. Clinical review 163: Hashimoto’s thyroiditis. J Clin Endocrinol Metab. 2003;88(9):4050-4058.
Weetman AP. Diseases associated with thyroid autoimmunity. Thyroid. 1998;8(9):793-796.
McLachlan SM, Rapoport B. Autoimmune response to the thyroid in humans: thyroid peroxidase, thyroglobulin, and thyrotropin receptor. Endocr Rev. 1992;13(2):192-206.
Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391-397.
Latrofa F, et al. Measurement of thyroglobulin autoantibodies in patients with autoimmune thyroid diseases: comparison of different assays and effect on thyroglobulin determination. J Clin Endocrinol Metab. 2003;88(2):804-807.
Spencer CA, et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab. 1998;83(4):1121-1127.
Cooper DS. Hyperthyroidism. Lancet. 2003;362(9382):459-468.
Vanderpump MP. The epidemiology of thyroid diseases. Br Med Bull. 2011;99:39-51.
Tozzoli R, et al. Evaluation of the diagnostic accuracy and predictive value of new assays for thyroid autoantibodies in autoimmune thyroid disease. Clin Chem. 2002;48(11):2035-2043.
Mariotti S, et al. A new immunoradiometric assay of thyroglobulin autoantibodies: clinical value in thyroid diseases and relation to endogenous thyroglobulin. J Clin Endocrinol Metab. 1983;56(4):726-733.
Papanastasiou L, et al. The clinical significance of thyroglobulin antibodies in patients with differentiated thyroid cancer. Eur J Endocrinol. 2007;157(5):619-625.
Demers LM, Spencer CA. NACB guidelines for use of laboratory tests to support the diagnosis and management of thyroid diseases. Clin Chem. 2003;49(1):128-135.
Baloch Z, et al. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13(1):3-126.
Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29(1):76-131.
Premawardhana LD, et al. The natural history of postpartum thyroiditis: application of a novel diagnostic scoring system. J Clin Endocrinol Metab. 2000;85(4):1535-1542.
Rotondi M, et al. Difficulties in measuring thyroglobulin in patients with autoimmune thyroid disease. Eur J Endocrinol. 2008;159(3):311-316.
FAQ’s:
What is thyroglobulin?
It is a prohormone glycoprotein stored in the thyroid gland.What causes anti-thyroglobulin antibodies?
Autoimmune thyroid diseases like Hashimoto’s and Graves’ disease.What are the common symptoms?
Fatigue, weight changes, temperature intolerance, and neck swelling.When is testing indicated?
To diagnose autoimmune thyroid conditions and thyroid cancer.How should patients prepare?
Fast for twelve hours and avoid biotin and oral contraceptives.What is the sample requirement?
A 3.0 ml blood sample collected in a red-capped tube.What is the normal range?
The reference range is 0.0 to 4.0 IU/mL.What causes test interference?
Biotin, oral contraceptives, heterophile antibodies, and HAMA.Who is more prone?
Older individuals, particularly women, may present with raised antibodies.What conditions show high levels?
Hashimoto’s, Graves’ disease, rheumatoid arthritis, and diabetes mellitus.Related Tests
- Thyroid-Stimulating Hormone (TSH) Test
- Thyroglobulin (Tg)
